Data on CUX1 isoforms in idiopathic pulmonary fibrosis lung and systemic sclerosis skin tissue sections For immunohistochemistry, sections were pretreated with methanol, followed by antigen retrieval in heated 10-mM citrate buffer (pH 6).
Experimental features
The primary antibodies were CUX1 antibody (0.2 mg/ml) and the monoclonal anti-α-SMA clone, 1a Cy3-conjugated antibody (0.7 mg/ml). Sections were sequentially incubated with a 1/200 dilution of an Alexa 488 secondary antibody.
Data source location
London, United Kingdom
Data accessibility Data presented in this article

Value of the data
The data provides the evidence that CUX1 isoforms localise within α-smooth muscle actin-positive cells in SSc skin tissue sections, especially in the granular and prickle cell layers.
The data provides the evidence that CUX1 isoforms localise within α-smooth muscle actin-positive cells at the fibrotic loci in idiopathic pulmonary fibrosis (IPF) lung tissue sections.
The data could further help research on the function of CUX1 isoforms in fibrosis-related diseases.
Data
Immunohistochemistry revealed the presence of α-SMA-positive fibrotic loci, which are characteristic in the lungs of patients with IPF and in the skin of patients with SSc. In the IPF tissue sections, CUX1 localised at alveolar cells and fibrotic loci. In addition, CUX1 localised within α-SMApositive cells but was not observed in the normal lung section (Fig. 1) . In the SSc skin tissue sections, CUX1 co-localised with α-SMA at the granular cell layer, prickle cell layer and fibrotic loci in the epidermis. In addition, CUX1 localised within α-SMA-positive cells. These were not observed at the epidermis in the normal skin sections (Fig. 2) .
Experimental design, materials and methods
For formalin-fixed, paraffin-embedded specimens, the tissues were fixed and hydrated as described previously [1, 2] . For immunohistochemistry, the sections were pretreated with methanol (VWR, Lutterworth, UK), followed by antigen retrieval in heated 10-mM citrate buffer (pH 6). The primary antibodies were CUX1 antibody (0.2 mg/ml) and the monoclonal anti-α-SMA clone, 1a Cy3-conjugated antibody (0.7 mg/ml). The sections were sequentially incubated with a 1/200 dilution of an Alexa 488 secondary antibody. The slides were viewed and photographed using a Zeiss Axioscope light microscope with Axiovision software.
